(Q71082875)
Statements
Optimal recognition of neutral endopeptidase and angiotensin-converting enzyme active sites by mercaptoacyldipeptides as a means to design potent dual inhibitors (English)
Coric P
Turcaud S
Meudal H
Roques BP
Fournie-Zaluski MC